Abstract
Pediatric chronic myeloid leukemia is a rare entity (2-5% of childhood
leukemias) classified as a myeloproliferative neoplasia characterized by
the presence of the BCR-ABL fusion gene, the oncogenic translocation
product (9; 22) responsible for the disease through its deregulated
tyrosine kinase activity.